Asiatic Laboratories Limited (DSE:ASIATICLAB)

Market Cap	5.45B
Revenue (ttm)	1.47B
Net Income (ttm)	268.56M
Shares Out	122.39M
EPS (ttm)	3.06
PE Ratio	14.56
Forward PE	n/a
Dividend	1.00 (2.32%)
Ex-Dividend Date	n/a

Volume	3,407,569
Average Volume	1,969,009
Open	43.40
Previous Close	43.10
Day's Range	43.40 - 45.20
52-Week Range	27.80 - 54.70
Beta	n/a
RSI	77.61
Earnings Date	Oct 30, 2025

About Asiatic Laboratories

Asiatic Laboratories Limited manufactures and markets pharmaceutical products in Bangladesh and internationally. The company offers products in the categories of antihistamines and respiratory care; cardiac and eye care; antibiotics, antifungals and antiprotozoals; vitamins and minerals; antiulcerants and antiemetics; dermatological products; antipsychotics and tranquilizers; and non-steroidal anti-inflammatory drugs. It distributes its products through sales distribution centers and a store. The company also exports its products. Asiatic Labor...

• Industry: Pharmaceutical Preparations
• Founded: 1970
• Employees: 777
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ASIATICLAB

Financial Performance

In 2022, Asiatic Laboratories's revenue was 1.47 billion, an increase of 1.48% compared to the previous year's 1.45 billion. Earnings were 268.56 million, a decrease of -16.21%.